Lisa Nicole Segnitz, MD
Hospice/Palliative Care · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: 051526 · Dominican Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Segnitz’s office at (650) 254-5200 to ask if they take your plan before you enroll.
California Medical Board record
Licence A82396 · Current
Licensed to practise in California · since 2003 · expires 2027-01-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Dominican HospitalSanta Cruz, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 68% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative sepsis rate: 11.66 (8.02 to 15.3) · 412 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.169, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.489, Oct 2024 – Sep 2025
See every measure and the patient survey for Dominican Hospital
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative sepsis rateComplications and deaths | 11.66 (8.02 to 15.3) · 412 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.169 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.489 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0.06 to 1.95) · 1,248 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.85 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.37 (94.33 to 174.41) · 132 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 534 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.8 · 491 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 2,973 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 7,510 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,695 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (1.44 to 5.4) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.26 (0 to 2.76) · 436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.85 (0.4 to 3.29) · 1,474 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.73 (3 to 14.46) · 437 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.03) · 343 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.17) · 6,336 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.615 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.937 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 212 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 505 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 45 · 237 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.5 · 594 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.9 · 510 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 473 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 7.8) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13 (9.4 to 17.7) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.4 to 15.4) · 1,585 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 390 cases | No different | Jan 2024 – Dec 2024 |
What patients said (774 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 32% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$48,222
Medicare paid this office $48,222 for 123 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 50 | $15,421 | $141 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 51 | $12,695 | $149 |
| Advance care planning, first 30 minutes | 49 | $4,613 | $66 |
| Residence visit for new patient with high level of medical decision making, per day at least 75 minutes | 25 | $4,158 | $166 |
| New patient visit (60+ min) | 17 | $2,980 | $175 |
See all 6 services
| Long return visit (40+ min) | 50 | $15,421 | $141 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 51 | $12,695 | $149 |
| Advance care planning, first 30 minutes | 49 | $4,613 | $66 |
| Residence visit for new patient with high level of medical decision making, per day at least 75 minutes | 25 | $4,158 | $166 |
| New patient visit (60+ min) | 17 | $2,980 | $175 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $2,950 | $140 |
Who their Medicare patients are
123 Original Medicare patients in 2024. Average age 78 · Under 65 12% · 85 and older 33% · Women 66% · Also on Medicaid 35% · Health risk score 2.81. At or below the middle of the specialty; the typical hospice and palliative care clinician is at 2.98.
Conditions among them: High blood pressure 75% · Depression 44% · Chronic kidney disease 36% · Cancer 32% · Dementia 31% · Heart failure 29% · Atrial fibrillation 29% · Diabetes 28% · Coronary heart disease 28% · COPD 23% · Stroke 10%.
The office billed $197,874, Medicare allowed $62,777 and paid $48,222; for 398 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 123 | 398 | 78 | 2.81 | $197,874 | $48,222 |
| 2023 | 103 | 404 | 79 | 2.90 | $176,912 | $45,847 |
| 2022 | 113 | 389 | 79 | 2.30 | $162,881 | $45,211 |
| 2021 | 112 | 384 | 79 | 2.40 | $151,889 | $44,725 |
| 2020 | 115 | 346 | 79 | 2.30 | $129,083 | $38,947 |
| 2019 | 116 | 302 | 81 | 2.28 | $134,695 | $35,526 |
| 2018 | 101 | 329 | 79 | 2.29 | $136,997 | $36,979 |
| 2017 | 104 | 334 | 78 | 2.25 | $127,495 | $33,900 |
| 2016 | 149 | 442 | 80 | 2.15 | $163,894 | $42,803 |
| 2015 | 129 | 373 | 80 | 2.30 | $140,108 | $40,707 |
| 2014 | 75 | 190 | 81 | 2.33 | $77,558 | $20,205 |
| 2013 | 42 | 129 | 83 | 2.41 | $54,102 | $14,274 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Long return visit (40+ min) | 44 | $17,235 | $149 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 40 | $8,701 | $140 |
| Advance care planning, first 30 minutes | 65 | $6,622 | $69 |
| New patient visit (60+ min) | 20 | $3,839 | $192 |
| Residence visit for new patient with high level of medical decision making, per day at least 75 minutes | 18 | $2,948 | $164 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 14 | $579 | $28 |
2022: 8 services
| Long return visit (40+ min) | 48 | $14,154 | $147 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 34 | $9,457 | $143 |
| Advance care planning, first 30 minutes | 44 | $3,992 | $73 |
| New patient visit (60+ min) | 14 | $2,697 | $193 |
| Telephone medical discussion with physician, 21-30 minutes | 19 | $2,334 | $101 |
| Residence visit for new patient with high level of medical decision making, per day at least 75 minutes | 12 | $1,810 | $151 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $1,202 | $71 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 13 | $518 | $26 |
2021: 11 services
| Long return visit (40+ min) | 38 | $10,396 | $149 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 43 | $9,706 | $147 |
| Advance care planning, first 30 minutes | 50 | $3,940 | $73 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 21 | $3,124 | $108 |
| Telephone medical discussion with physician, 21-30 minutes | 22 | $2,785 | $96 |
| Residence visit for new patient with moderate level of medical decision making, per day at least 60 minutes | 17 | $2,497 | $147 |
| Residence visit for new patient with high level of medical decision making, per day at least 75 minutes | 13 | $2,464 | $190 |
| New patient visit (60+ min) | 12 | $2,118 | $176 |
| Return visit (30+ min) | 13 | $1,617 | $116 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $1,284 | $71 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $535 | $41 |
2020: 9 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 44 | $9,527 | $144 |
| Long return visit (40+ min) | 37 | $5,799 | $126 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $4,397 | $98 |
| Advance care planning, first 30 minutes | 37 | $3,306 | $75 |
| New patient visit (60+ min) | 14 | $2,534 | $181 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 17 | $2,371 | $113 |
| Residence visit for new patient with high level of medical decision making, per day at least 75 minutes | 12 | $2,206 | $184 |
| Residence visit for new patient with moderate level of medical decision making, per day at least 60 minutes | 11 | $1,498 | $136 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,401 | $67 |
2019: 7 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 37 | $7,836 | $142 |
| Long return visit (40+ min) | 29 | $6,271 | $121 |
| Advance care planning, first 30 minutes | 60 | $4,858 | $71 |
| Residence visit for new patient with moderate level of medical decision making, per day at least 60 minutes | 23 | $3,419 | $149 |
| New patient visit (60+ min) | 18 | $3,181 | $177 |
| Residence visit for new patient with high level of medical decision making, per day at least 75 minutes | 15 | $2,682 | $179 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 15 | $1,473 | $87 |
2018: 7 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 35 | $7,998 | $143 |
| Long return visit (40+ min) | 29 | $7,522 | $119 |
| Advance care planning, first 30 minutes | 45 | $3,864 | $70 |
| New patient visit (60+ min) | 18 | $3,110 | $173 |
| Return visit (30+ min) | 16 | $2,185 | $91 |
| Residence visit for new patient with moderate level of medical decision making, per day at least 60 minutes | 13 | $1,863 | $143 |
| Extended patient service without direct patient contact, first hour | 14 | $1,476 | $82 |
2017: 9 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 28 | $5,298 | $136 |
| Long return visit (40+ min) | 31 | $5,234 | $119 |
| Advance care planning, first 30 minutes | 55 | $4,458 | $67 |
| Return visit (30+ min) | 20 | $3,251 | $88 |
| New patient visit (60+ min) | 15 | $2,548 | $170 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 19 | $2,202 | $82 |
| Residence visit for new patient with moderate level of medical decision making, per day at least 60 minutes | 14 | $2,092 | $149 |
| Extended office or other outpatient service, first hour | 11 | $1,487 | $106 |
| Extended patient service without direct patient contact, first hour | 12 | $1,461 | $91 |
2016: 10 services
| Advance care planning, first 30 minutes | 84 | $6,737 | $67 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 28 | $5,299 | $132 |
| Residence visit for new patient with moderate level of medical decision making, per day at least 60 minutes | 35 | $4,855 | $139 |
| Long return visit (40+ min) | 23 | $3,801 | $109 |
| Return visit (30+ min) | 26 | $3,707 | $88 |
| New patient visit (60+ min) | 21 | $3,538 | $168 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 28 | $3,398 | $94 |
| Residence visit for new patient with high level of medical decision making, per day at least 75 minutes | 12 | $1,935 | $161 |
| Extended office or other outpatient service, first hour | 13 | $1,058 | $81 |
| Short return visit (20+ min) | 12 | $841 | $56 |
2015: 9 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 38 | $7,742 | $146 |
| Extended office or other outpatient service, first hour | 72 | $6,738 | $83 |
| Residence visit for new patient with moderate level of medical decision making, per day at least 60 minutes | 24 | $3,690 | $154 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 20 | $2,916 | $104 |
| Long return visit (40+ min) | 16 | $2,527 | $110 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,224 | $171 |
| Residence visit for new patient with high level of medical decision making, per day at least 75 minutes | 11 | $2,045 | $186 |
| Extended inpatient or observation hospital service, first hour | 18 | $1,865 | $78 |
| Return visit (30+ min) | 13 | $1,473 | $92 |
2014: 4 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 23 | $4,304 | $134 |
| Extended office or other outpatient service, first hour | 28 | $2,630 | $80 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 16 | $1,650 | $92 |
| Extended inpatient or observation hospital service, first hour | 15 | $1,114 | $74 |
2013: 2 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 17 | $3,872 | $138 |
| Extended office or other outpatient service, first hour | 24 | $2,351 | $78 |
Medicaid work
$989 in 2023
Medicaid paid $989 for 14 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 14 | $989 |
| 2023 | 14 | 1 | 13 | $989 |
Drugs they prescribed that Part D paid
$10,571
Pharmacies billed $10,571 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 24% of their Part D prescriptions (70 of 289) in 2024. At or below the middle of the specialty; the typical hospice and palliative care clinician is at 43%. Long-acting opioids: 41% of their opioid prescriptions.
280 generic and fewer than 11 brand-name prescriptions · $10,571 in drug cost · 31 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Morphine Sulfate Er | 14 | $304 | $22 |
| Escitalopram | 22 | $233 | $11 |
| Hydrocodone-Acetaminophen | 14 | $231 | $17 |
| Methadone | 15 | $220 | $15 |
| Quetiapine | 24 | $139 | $6 |
See all 8 drugs
| Morphine Sulfate Er | 14 | $304 | $22 |
| Escitalopram | 22 | $233 | $11 |
| Hydrocodone-Acetaminophen | 14 | $231 | $17 |
| Methadone | 15 | $220 | $15 |
| Quetiapine | 24 | $139 | $6 |
| Trazodone | 14 | $88 | $6 |
| Gabapentin | 13 | $22 | $2 |
| Omeprazole | 13 | $17 | $1 |
Year by year
| 2024 | 289 | 78 | 24% (70) | None | $10,571 |
| 2023 | 252 | 67 | 33% (83) | None | $9,158 |
| 2022 | 323 | 65 | 21% (68) | None | $9,687 |
| 2021 | 354 | 72 | 22% (76) | 7% | $14,783 |
| 2020 | 404 | 73 | 28% (113) | 15% | $21,733 |
| 2019 | 337 | 63 | 26% (88) | 14% | $18,639 |
| 2018 | 239 | 55 | 42% (101) | 5% | $6,907 |
| 2017 | 223 | 52 | 29% (64) | 12% | $7,456 |
| 2016 | 396 | 73 | 27% (107) | 18% | $17,796 |
| 2015 | 177 | 45 | 21% (37) | 22% | $10,887 |
| 2014 | 160 | 30 | 24% (39) | 18% | $7,321 |
| 2013 | 74 | 29 | 24% (18) | None | $2,427 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Mirtazapine | 18 | $532 | $30 |
| Hydrocodone-Acetaminophen | 15 | $452 | $30 |
| Methadone | 19 | $315 | $17 |
| Morphine Sulfate Er | 14 | $299 | $21 |
2022: 7 drugs
| Mirtazapine | 30 | $1,249 | $42 |
| Gabapentin | 22 | $667 | $30 |
| Tramadol | 16 | $546 | $34 |
| Hydrocodone-Acetaminophen | 16 | $384 | $24 |
| Clonazepam | 11 | $346 | $31 |
| Omeprazole | 17 | $308 | $18 |
| Methadone | 18 | $303 | $17 |
2021: 10 drugs
| Gabapentin | 44 | $803 | $18 |
| Mirtazapine | 16 | $644 | $40 |
| Morphine Sulfate Er | 20 | $423 | $21 |
| Hydrocodone-Acetaminophen | 15 | $368 | $25 |
| Omeprazole | 20 | $249 | $12 |
| Methadone | 14 | $233 | $17 |
| Escitalopram | 12 | $123 | $10 |
| Bupropion Xl | 14 | $115 | $8 |
| Trazodone | 14 | $97 | $7 |
| Lorazepam | 13 | $71 | $5 |
2020: 14 drugs
| Linzess | 12 | $5,614 | $468 |
| Oxycontin | 11 | $4,345 | $395 |
| Morphine Sulfate Er | 28 | $636 | $23 |
| Gabapentin | 22 | $463 | $21 |
| Oxycodone | 13 | $447 | $34 |
| Hydrocodone-Acetaminophen | 26 | $416 | $16 |
| Erythromycin | 11 | $323 | $29 |
| Quetiapine | 15 | $321 | $21 |
| Lorazepam | 14 | $268 | $19 |
| Mirtazapine | 13 | $254 | $20 |
| Bupropion Xl | 11 | $250 | $23 |
| Omeprazole | 19 | $242 | $13 |
| Paroxetine | 11 | $119 | $11 |
| Lactulose | 11 | $78 | $7 |
2019: 9 drugs
| Oxycodone | 16 | $874 | $55 |
| Mirtazapine | 12 | $490 | $41 |
| Hydrocodone-Acetaminophen | 24 | $450 | $19 |
| Morphine Sulfate Er | 13 | $420 | $32 |
| Quetiapine | 11 | $236 | $21 |
| Cephalexin | 20 | $202 | $10 |
| Eszopiclone | 13 | $85 | $7 |
| Nortriptyline | 12 | $74 | $6 |
| Metoclopramide | 12 | $40 | $3 |
2018: 5 drugs
| Hydrocodone-Acetaminophen | 41 | $815 | $20 |
| Gabapentin | 12 | $314 | $26 |
| Lactulose | 17 | $227 | $13 |
| Methadone | 14 | $171 | $12 |
| Fluoxetine | 12 | $136 | $11 |
2017: 4 drugs
| Morphine Sulfate Er | 19 | $794 | $42 |
| Lactulose | 28 | $291 | $10 |
| Hydrocodone-Acetaminophen | 13 | $194 | $15 |
| Gabapentin | 11 | $145 | $13 |
2016: 11 drugs
| Oxycontin | 14 | $3,627 | $259 |
| Morphine Sulfate Er | 23 | $1,109 | $48 |
| Hydrocodone-Acetaminophen | 15 | $1,015 | $68 |
| Mirtazapine | 24 | $584 | $24 |
| Methylphenidate | 15 | $449 | $30 |
| Hydromorphone | 11 | $232 | $21 |
| Lactulose | 17 | $195 | $11 |
| Lorazepam | 16 | $157 | $10 |
| Methadone | 13 | $156 | $12 |
| Citalopram Hbr | 33 | $152 | $5 |
| Trazodone | 13 | $116 | $9 |
2015: 2 drugs
| Gabapentin | 23 | $285 | $12 |
| Trazodone | 20 | $91 | $5 |
2014: 5 drugs
| Morphine Sulfate Er | 12 | $1,249 | $104 |
| Morphine Sulfate | 16 | $311 | $19 |
| Lactulose | 18 | $209 | $12 |
| Gabapentin | 17 | $193 | $11 |
| Potassium Chloride | 13 | $137 | $11 |
Money from drug and device companies
$82 in 2024
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | None | $51 | 1 payment
|
| Eisai | Lenvima | $32 | 1 payment
|
See all 2 published payments
| Eisai | Meals · 2024-11-07 | Lenvima | $32 |
| AstraZeneca Pharmaceuticals LP | Meals · 2024-06-25 | None | $51 |
Professional record
- NPI
- 1912907080
- Licence
- CA 00A823960, CA A82396California A82396: Current · expires 2027-01-31
- Trained
- University of California, San Francisco School of Medicine, 2000
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A823960
- Taxonomy
- Federal specialty code 207QH0002X (207QH0002X); Family medicine (207Q00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2005-07-29
- NPI last updated
- 2015-05-13
This is when the NPI record was last certified, not a medical board exam.